Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sanara MedTech ( (SMTI) ) has shared an update.
Sanara MedTech Inc. has released an investor presentation that outlines its priorities and strategy for the 2026 fiscal year. This presentation will be used in meetings with investors and analysts, including at the Piper Sandler 37th Annual Healthcare Conference in New York on December 3, 2025. The presentation is intended to provide context alongside the company’s SEC filings and public announcements, and it highlights the company’s strategic direction for the coming year.
The most recent analyst rating on (SMTI) stock is a Hold with a $18.00 price target. To see the full list of analyst forecasts on Sanara MedTech stock, see the SMTI Stock Forecast page.
Spark’s Take on SMTI Stock
According to Spark, TipRanks’ AI Analyst, SMTI is a Neutral.
Sanara MedTech’s overall score is primarily impacted by its financial struggles and bearish technical indicators. Despite strong revenue growth highlighted in the earnings call, the company’s profitability issues and negative valuation metrics weigh heavily on the stock’s attractiveness.
To see Spark’s full report on SMTI stock, click here.
More about Sanara MedTech
Sanara MedTech Inc. operates in the healthcare industry, focusing on medical technologies and solutions. The company is known for its innovative products and services aimed at improving patient care and outcomes.
Average Trading Volume: 36,025
Technical Sentiment Signal: Sell
Current Market Cap: $182M
See more data about SMTI stock on TipRanks’ Stock Analysis page.